Seeing Is Believing
Currently out of the existing stock ratings of Jasper Hellweg, 136 are a BUY (85.53%), 23 are a HOLD (14.47%).
Analyst Jasper Hellweg, currently employed at ARGUS, carries an average stock price target met ratio of 73.81% that have a potential upside of 15.18% achieved within 259 days.
Jasper Hellweg’s has documented 299 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Industrials, Technology, Consumer Cyclical, Basic Materials sectors.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 30-Sep-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/11/2020. The price target of $88 was fulfilled within 2 days with a profit of $5.56 (6.74%) receiving and performance score of 33.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jul-2021
$617
4 years 3 months 15 days ago
(22-Jun-2022)
4/6 (66.67%)
$95.47 (18.31%)
149
Buy Since 17-Jun-2022
$550
4 years 3 months 20 days ago
(17-Jun-2022)
0/1 (0%)
$95.24 (20.94%)
Buy Since 27-Apr-2017
$596
$113.42 (23.50%)
$574
4 years 4 months 10 days ago
(27-May-2022)
3/5 (60%)
$76.79 (14.79%)
741
Buy Since 19-May-2021
$580
$97.42 (20.19%)
$500
4 years 4 months 12 days ago
(25-May-2022)
3/4 (75%)
$76.52 (15.20%)
177
Buy Since 01-Nov-2018
$625
$142.42 (29.51%)
$510
4 years 5 months 12 days ago
(25-Apr-2022)
5/6 (83.33%)
$119.43 (23.62%)
427
Which stock is Jasper Hellweg most bullish on?
Which stock is Jasper Hellweg most reserved on?
What Year was the first public recommendation made by Jasper Hellweg?